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SIRT1 Regulates Lamellipodium Extension and
Migration of Melanoma Cells
Risa Kunimoto1,2, Kowichi Jimbow2, Akihiko Tanimura3, Masahiro Sato1,2, Kouhei Horimoto1,2,
Takashi Hayashi1,5, Shin Hisahara1,5, Toshiya Sugino1,6, Tomohisa Hirobe4, Toshiharu Yamashita2 and
Yoshiyuki Horio1
Melanoma is highly metastatic, but the mechanism of melanoma cell migration is still unclear. We found that
melanoma cells expressed the nicotinamide adenine dinucleotide–dependent protein deacetylase SIRT1 in the
cytoplasm. Cell membrane extension and migration of melanoma cells were inhibited by SIRT1 inhibitors or
SIRT1 knockdown, whereas SIRT1 activators enhanced elongation of protrusion and cellular motility. In B16F1
cells, growth factor stimulation induced lamellipodium extension, a characteristic feature at the leading edge of
migrating cells, and SIRT1 was found in the lamellipodium. SIRT1 inhibitor nicotinamide (NAM) or SIRT1 small
interfering RNAs suppressed the lamellipodium extension by serum or platelet-derived growth factor (PDGF).
The lamellipodium formation by dominant-active Rac1 was also inhibited by NAM, a SIRT1 inhibitor. NAM
inhibited the accumulation of phosphorylated Akt at the submembrane by serum or PDGF. Using fluorescence
resonance energy transfer, we found that NAM impaired PDGF-dependent increase in the phosphatidylinositol-
3,4,5-trisphosphate level at the leading edge. NAM inhibited the abdominal metastasis of transplanted B16F1
melanoma cells in C57BL6/J mice and improved survival. Finally, SIRT1-knockdown B16F1 cells showed
significantly reduced metastasis in transplanted mice compared with that in control B16F1 cells. These results
indicate that SIRT1 inhibition is a strategy to suppress metastasis of melanoma cells.
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INTRODUCTION
Melanoma is highly metastatic. Migrating melanoma cells
exhibit characteristic sheet-like membrane extensions called
lamellipodia at their leading edge, which are induced by
growth factor stimulation. This process begins with the activa-
tion of phosphatidylinositol-3-kinase (PI3K), which forms
phosphatidylinositol-3,4,5-trisphosphate (PIP3). The increased
PIP3 recruits WASP family verprolin-homologous proteins
(WAVE), which induce actin polymerization by the Arp2/3
complex, leading to the formation of membrane ruffles and
lamellipodia (Takenawa and Suetsugu, 2007; Ridley, 2011).
The accumulation of PIP3 also activates and recruits Rac1, a
small GTPase, to the leading edge, and the activated Rac1
potentiates the WASP family verprolin-homologous protein
complex to extend lamellipodia (Takenawa and Suetsugu,
2007; Ridley, 2011). In addition, cortactin, a cytoskeletal
scaffolding protein, is recruited to the cell periphery, binds the
Arp2/3 complex, stabilizes Arp2/3 complex–induced actin
branches, and affects lamellipodium persistence (Takenawa
and Suetsugu, 2007; Ridley, 2011).
SIRT1, one of the nicotinamide adenine dinucleotide
(NADþ )-dependent protein deacetylases (sirtuins), is a homo-
log of yeast Sir2 and modulates numerous physiological
functions (Horio et al., 2011). Small molecules such as
nicotinamide (NAM) inhibit SIRT1, whereas resveratrol, a
polyphenol, and NADþ activate SIRT1 activity (Horio et al.,
2011). Sir2 interacts with actin and participates in forming
cellular polarity, which enables the removal of damaged
proteins from a daughter to a mother cell in budding yeast
(Liu et al., 2010). Effect on cytoskeletal components by SIRT1
is unclear, but recently cytoplasmic SIRT1 has been shown to
dictate autophagy (Morselli et al., 2011), indicating that SIRT1
can interact with actin cytoskeleton. We reported that neural
precursor cells express SIRT1 in the cytoplasm, and SIRT1-
knockdown in these cells severely impairs cell migration from
ORIGINAL ARTICLE
1Department of Pharmacology, Sapporo Medical University, Sapporo, Japan;
2Department of Dermatology, Sapporo Medical University, Sapporo, Japan;
3Department of Pharmacology, School of Dentistry, Health Sciences University
of Hokkaido, Ishikari-Tobetsu, Japan and 4Radiation Risk Reduction Research
Program, National Institute of Radiological Sciences, Chiba, Japan
Correspondence: Yoshiyuki Horio, Department of Pharmacology, Sapporo
Medical University, S1, W17, Chu-ouku, Sapporo 060-8556, Japan.
E-mail: horio@sapmed.ac.jp
5Current address: Department of Neurology, Sapporo Medical University,
Sapporo 060-8556, Japan.
6Current address: Department of Neurosurgery, Sapporo Medical University,
Sapporo 060-8556, Japan.
Received 25 March 2013; revised 14 December 2013; accepted 17
December 2013; accepted article preview online 30 January 2014; published
online 27 February 2014
Abbreviations: FRET, fluorescence resonance energy transfer; NAM,
nicotinamide; pAkt, phosphorylated Akt; PI3K, phosphatidylinositol-3-kinase;
PIP3, phosphatidylinositol-3,4,5-trisphosphate
& 2014 The Society for Investigative Dermatology www.jidonline.org 1693
the ventricular zone to the cortical plate (Hisahara et al.,
2008). Moreover, the SIRT1-knockdown neural precursor
cells have much shorter protrusions compared with control
cells (Hisahara et al., 2008). The extension of neural processes
from PC12 pheochromocytoma cells is enhanced by the over-
expression of cytoplasmic SIRT1, whereas it is impaired by
SIRT1 inhibitors or SIRT1 small interfering RNAs (SIRT1-
siRNA) (Sugino et al., 2010). SIRT1 may interact with cyto-
skeleton and affect the formation and extension of protrusions
as well as cellular migration.
In this study, we found that SIRT1 was involved in
melanoma cell migration and SIRT1 inhibition suppressed
metastasis of B16F1 melanoma cells in vivo. A fluorescence
resonance energy transfer (FRET) study suggested that SIRT1
affected PIP3 level at the leading edge.
RESULTS
Modulation of SIRT1 affects melanoma cell migration
SIRT1 was expressed in the cytoplasm of mouse B16F1,
human MM418 melanoma cells (Townsend et al., 1992),
and melanoblasts isolated from the epidermis of newborn
mice (Figure 1a). Reverse transcriptase-PCR and western blot
analyses also showed the expression of SIRT1 in B16F1,
B16F10, and MM418 melanoma cells (Figure 1b). Although
SIRT1 protein level of B16F1 cells was much higher than that
of B16F10 cells (Figure 1b), we found that SIRT1 expression
levels in B16F1 and B16F10 cells were affected by cell culture
density and that SIRT1 expression levels were similar in B16F1
and B16F10 cells in the same cell density condition
(Supplementary Figure S1a online). The subcellular fractiona-
tion of B16F1 cells showed SIRT1 expression in the cytoplasm
(Figure 1c).
We examined the effect of SIRT1 modulators on the
migration of melanoma cells. In scratch assays, the wound
healing of B16F1 (Figure 1d and Supplementary Figure S1b
online) and B16F10 cells (Supplementary Figure S1c online)
was significantly blocked by NAM, an inhibitor of sirtuins,
whereas NADþ , an activator of SIRT1, promoted wound
healing (Figure 1d and Supplementary Figure S1b online).
Transwell migration assays also showed that the invasion of
melanoma cells was significantly inhibited by NAM, whereas
NADþ promoted the invasion of these cells (Figure 1e and
Supplementary Figure S1d and f online). The administration of
resveratrol, another activator of SIRT1, significantly promoted
the migration of B16F1 cells (Figure 1e), whereas the sirtuin
inhibitor splitomicin inhibited the migration of B16F10 cells
(Supplementary Figure S1f online). These agents did not affect
the proliferation of B16F1 cells (Supplementary Figure S1g
online). NAM also inhibited cell migration of WM266-4,
Mewo, G361, SK-MEL-24, and MM418 human melanoma
cells (Supplementary Figure S2 online). In addition, splitomi-
cin reduced migration of MM418 cells (Supplementary Figure
S2 online).
Regardless of whether SIRT1 contributes to the migration,
SIRT1 small interfering RNAs (SIRT1-siRNAs) were expressed
in B16F1 cells (Figure 1f and g). Knockdown of SIRT1
significantly reduced the mobility of B16F1 cells (Figure 1h
and Supplementary Figure S1e online). The sirtuin family
consists of seven members, SIRT1–SIRT7. We examined the
effect of sirtuin-shRNA lentivirus on the migration of B16F1
cells. Although SIRT2 is reported to suppress cell adhesion and
migration (Pandithage et al., 2008), SIRT2-shRNA did not
affect the movement of B16F1 cells (Supplementary Figure S3
online). Cell migration was also not affected by shRNAs for
SIRT3, 4, 5, 6, or 7 (Supplementary Figure S3 online). In
addition, the tumor suppressor p53 participates in RhoA-
ROCK-dependent cell migration and invasion (Muller et al.,
2011). Because SIRT1 deacetylates and inhibits p53 (Horio
et al., 2011), we examined the effect of p53-siRNA on B16F1
cells. However, NAM-dependent inhibition of the B16F1 cell
migration was not affected by p53 knockdown (Supplementary
Figure S4a and b online). We also examined the effect of NAM
on p53þ /þ or p53 / HCT116 human colorectal carcinoma
cells and found that NAM did not inhibit the cell migration of
these cells (Supplementary Figure S4c online).
SIRT1 localizes to the lamellipodium and affects lamellipodium
formation
We found that SIRT1 modulators affected protrusion extension
in melanoma cells. Whereas cells treated with NADþ or
resveratrol often extended long protrusions, NAM decreased
the length of the protrusions in B16F1 melanoma cells
(Supplementary Figure S5a and b online). SIRT1 immunor-
eactivity was relatively high in the tips of protrusions
(Supplementary Figure S5a online, insets online). Interestingly,
SIRT1 modulators did not affect the number of protrusions per
cell (Supplementary Figure S5c online).
Migrating melanoma cells exhibit an elongated shape with a
ruffling lamellipodium at the leading edge. B16F1 cells cultured
overnight in the absence of serum barely had lamellipodia,
which were induced shortly after addition of serum or growth
factors. SIRT1 was diffusely distributed in the cytoplasm of
unstimulated cells (upper panels of Figure 2a); in contrast,
serum induced lamellipodia where SIRT1 existed (lower panels
of Figure 2a). SIRT1 is known to bind cortactin (Zhang et al.,
2009), and immunoprecipitation of SIRT1 showed that SIRT1
bound cortactin in B16F1 cells (right panels of Figure 2a).
Serum stimulation did not affect the binding between SIRT1
and cortactin (right panels of Figure 2a). Time-lapse images of
B16F10 cells in a wound-healing assay showed that lamelli-
podia were formed at the leading edge of migrating cells
(Supplementary Movie S1 online).
We found that SIRT1-knockdown by SIRT1-siRNAs severely
impaired lamellipodium extension by serum in B16F1 cells, in
which prominent actin stress fibers were observed (Figure 2b
and c). SIRT1 inhibitor NAM inhibited the lamellipodium
extension induced by platelet-derived growth factor (PDGF;
Figure 2d and e) or serum (Supplementary Figure S5d and e
online). NAM also blocked lamellipodium formation of
B16F10 cells (Supplementary Movie S2 online).
Growth factors activate PI3K and increase PIP3 levels in the
membrane. PIP3 recruits and increases phosphorylated Akt
(pAkt), a positive regulator of cell migration (Dillon and
Muller, 2010). pAkt and cortactin were diffusely distributed
in the cytoplasm of unstimulated cells, whereas they
accumulated at the submembrane of the leading edges after
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stimulation by PDGF (Figure 2d) or serum (Supplementary
Figure S5d online). Pretreatment with NAM inhibited the
membrane accumulation of pAkt and cortactin by PDGF
(Figure 2d) or serum (Supplementary Figure S5d online).
The activation of Rac1 induces and enhances lamellipo-
dium formation (Wu et al., 2009). We examined
Rac1-dependent lamellipodium formation. To identify Rac1-
transfected cells, enhanced green fluorescent protein (EGFP)
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Figure 1. Cytoplasmic SIRT1 promotes the migration of B16F1 cells. (a) Immunostaining of SIRT1 in melanoma cells and melanoblasts. Bars¼10mm. (b) Reverse
trancriptase–PCR (RT-PCR) and western blot analysis of SIRT1 in melanoma cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal
control. (c) Expression of SIRT1 in the cytoplasmic fraction of B16F1 cells. Lamin A/C and cytosolic aspartate aminotransferase (cAAT) were markers of the nucleus
and cytoplasm, respectively. (d, e) SIRT1 modulators affected B16F1 cell migration in wound-healing assay (d) and transwell migration assay (e). (f) SIRT1 small
interfering RNAs (SIRT1-siRNAs) suppressed SIRT1 mRNA expression. (g) Time course of SIRT1 protein expression levels in B16F1 cells after knockdown by si1-1.
(h) SIRT1–siRNAs suppressed the cell migration of B16F1 cells. Data from at least three independent experiments are represented as means±SD. *Po0.05,
**Po0.005; NS, no significance.
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was co-transfected. Although electroporation reduced the
number of B16F1 cells with lamellipodia, dominant-active
RacV12 alone could not induce lamellipodia in the absence of
growth factor stimulation (Supplementary Figure S6a and b
online). After serum stimulation, RacV12 increased the num-
ber of cells with lamellipodia compared with that of cells
transfected with EGFP alone (Figure 2f and g). NAM effectively
suppressed the lamellipodium extension induced by RacV12
(Figure 2f and g).
NAM inhibits the increase in PIP3 on the membrane of
B16F1 cells
NAM inhibited the membrane accumulation of pAkt, which is
recruited by PIP3 at the submembrane. To confirm the
function of PIP3, we first examined the effect of LY294002,
an inhibitor of PI3K, in B16F1 cells. LY294002 significantly
inhibited the migration as well as lamellipodium extension
induced by serum and PDGF (Figure 3a-c). LY294002 also
inhibited RacV12-dependent lamellipodium extension
(Figure 2f and g). Similar to LY294002, NAM may affect
PIP3 levels.
Fllip-pm, which generates a FRET signal upon binding PIP3,
or a control form, fllip-pm-R284C, which loses PIP3-binding
ability, was stably expressed in B16F1 cells, and the change in
PIP3 level following growth factor stimulation was monitored
by FRET (Sato et al., 2003). When PDGF was added to cells
expressing fllip-pm, the PIP3 level in a restricted area of the
membrane gradually increased, peaking for several minutes,
and returning to baseline 10 minutes after the addition of
PDGF (Figure 3d and e; Supplementary Movie S3 online).
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PDGF sometimes increased the PIP3 level at several points at
the submembrane and the increase in PIP3 was never detected
at the central region of the cell (Figure 3d and e;
Supplementary Movie S3 online).
Pretreatment of the cells with NAM inhibited the increase in
PIP3 (Figure 3d and f; Supplementary Movie S4 online),
although a transient increase in PIP3 was detected in some
NAM-treated cells with a much lower intensity and duration
than in control cells (Figure 3g and Supplementary Movie
S4 online). As expected, fllip-pm-R284C did not generate a
FRET signal (Figure 3d and Supplementary Movie S5 online).
These results indicated that SIRT1 affected the growth factor–
stimulated PIP3 levels.
Inhibition of metastasis of B16F1 cells by NAM and
SIRT1-knockdown in vivo
To investigate the effect of NAM in vivo, B16F1 cells were
subcutaneously transplanted into C57BL/6J mice, and the
abdominal invasion of melanoma cells was examined after
the mice died. The daily intraperitoneal administration of
NAM significantly reduced the abdominal invasion of tumor
cells; only 13% of these mice showed the metastasis of
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melanoma cells across the abdominal muscle walls, whereas
34% of control mice had abdominal metastasis (Figure 4a).
Kaplan–Meier analysis of the overall survival of the mice
showed that the NAM-treated mice had a significantly better
prognosis than the control mice (P¼ 0.02, log-rank test;
Figure 4b). The administration of NAM did not reduce the
tumor growth rate or tumor size in the transplanted region at
death (Supplementary Figure S7a and b online).
To confirm SIRT1’s effect on melanoma metastasis, mutant
B16F1 cell lines permanently expressing SIRT1-shRNA (sh9)
and control-shRNA (c4) were generated (Figure 4c). SIRT1
protein expression level of sh9 cells was 41% of that of control
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c4 cells (Supplementary Figure S7c online). Time-lapse images
of c4 cells (Supplementary Movie S6 online) and sh9 cells
(Supplementary Movie S7 online) showed that the lamellipo-
dium formation and migration of sh9 cells were impaired. In
scratch assays, sh9 cells had lower invasive activity compared
with c4 cells (Figure 4d), and the number of sh9 cells moved
to the lower chamber was only 11% of the number of
migrated c4 cells in transwell assays (Figure 4e). However,
this knockdown of SIRT1 barely affected cell proliferation
(Supplementary Figure S7d online). The c4 cells and sh9 cells
were transplanted into C57BL/6J mice. Abdominal and/or
lymph node metastasis were found in 18% of the mice
receiving SIRT1-knockdown sh9 cells and in 77% of the mice
transplanted with control c4 cells, respectively (Figure 4f).
There was no difference in the tumor growth rate or tumor size
in the transplanted regions at death (Supplementary Figure S7e
and f online). Intravenus injections of c4 and sh9 cells showed
that significantly lower metastasis of sh9 cells occurs in the
lung (Figure 4g).
DISCUSSION
SIRT1 was necessary for lamellipodium extension and migra-
tion of melanoma cells, in which SIRT1 was suggested to
participate in the increase and maintenance of PIP3 level in a
definite period of time in response to growth factor stimula-
tion. The time course of the change in PIP3 level observed in
the present study was consistent with previous studies using
PC12 cells (Aoki et al., 2005). PIP3 level is regulated by PI3K
and lipid phosphatases, which may be modulated by
acetylation and deacetylation. We examined PTEN, an
inositol 50 phosphatase and tumor suppressor, but could not
detect the expression in B16F1 cells (Supplementary Figure S8
online). At present, SIRT1’s target is unknown.
SIRT1 has been reported to regulate insulin signaling, which
increases the PIP3 level. SIRT1 enhances the insulin-mediated
Akt phosphorylation by reducing PTP-1B mRNA, a phospha-
tase targeting the insulin receptor (Sun et al., 2007), and by
increasing mRNA levels of Rictor, a mTORC2 subunit (Wang
et al., 2011), and PI3K (Schenk et al., 2011). These
modulations are mediated by transcriptional levels and take
a longer time than those examined in the present study. In
addition, SIRT1 deacetylates Akt in the PIP3-binding region,
which promotes Akt’s membrane localization and activation
(Sundaresan et al., 2011). Although this mechanism did not
affect PIP3 level, Akt’s activation by SIRT1 may enhance the
mobility of melanoma cells.
SIRT1 is reported to bind and deacetylate cortactin (Zhang
et al., 2009). Because cortactin is a downstream molecule of
PIP3 signaling, the modulation of cortactin by SIRT1 probably
does not affect the PIP3 level. Although only a small amount of
the cortactin was immunoprecipitated by the SIRT1 antibody
(Figure 2a), SIRT1’s recruitment to the lamellipodia may be
mediated by cortactin.
Serum was necessary for lamellipodium formation by
RacV12 (Supplementary Figure S6 online), which was inhib-
ited by LY294002 or NAM (Figure 2f and g). Our data showed
that an increase in PIP3 level is necessary for Rac1-induced
lamellipodium formation in B16F1 cells. Previously, the local-
ized activation of Rac1 had been shown to produce cell
motility and to control the direction of cell movement in
several types of cells (Wu et al., 2009), but these cells had
been examined in the presence of serum. Recently, Welf et al.
(2012) showed that activated Rac1 produces nascent
protrusions, but their growth requires PI3K signaling.
Compared with neurons expressing normal PI3K levels,
neurons expressing a mutant PI3K, which reduces the PIP3
level, exhibit shorter neurites (Jaworski et al., 2005). Increasing
the PIP3 level by the PTEN mutation significantly elongates
dendrites (Jaworski et al., 2005). These studies suggest that a
sustained increase in PIP3 level is indispensable in the
maturation and extension of lamellipodia, for which SIRT1
may modulate PIP3 turnover.
HCT116 cells were insensitive to SIRT1 inhibition
(Supplementary Figure S4c online), indicating that they use
other types of cell migration mechanisms (Takenawa and
Suetsugu, 2007; Ridley, 2011). Interestingly, endothelial cell
migration and blood vessel formation are diminished by the
SIRT1 disruption (Potente et al., 2007). Although the
regulation of FOXO1 by SIRT1 is responsible for the
mechanism, the modulation of PIP3 by SIRT1 may also have
a role in angiogenesis. Accordingly, endothelial cells express
SIRT1 in the nucleus and cytoplasm (Potente et al., 2007).
NAM effectively inhibited the melanoma invasion in mice
(Figure 4a). Oral administration of SIRT1 inhibition may be a
strategy for controlling melanoma metastasis. NAM is known
to be safe and is used to treat bullous pemphigoid, although
the dose for pemphigoid is lower than that used in the present
study. The development of SIRT1-specific inhibitors with low
toxicity may be necessary for melanoma treatment.
MATERIALS AND METHODS
Animals
All in vivo experiments were conducted according to The Animal
Guideline of Sapporo Medical University and approved by the
Animal Use Committee of Sapporo Medical University. Female 4-
week-old C57BL/6J mice (Sankyo Labo Service, Tokyo, Japan) were
used. B16F1 melanoma cells (1 106 cells per mouse) were sub-
cutaneously transplanted into mice (n¼ 20–25), which were divided
into two groups. NAM at a dose of 1 mg g 1 body weight (15 mg per
mouse) or phosphate buffered saline was intraperitoneally injected
into mice once a day from the day of transplantation to the day of
death. Experiments were carried out three times. Mutant B16F1 cell
lines permanently expressing SIRT1-shRNA (sh9) or control-shRNA
(c4) were also transplanted into C57BL/6J mice. Lung metastases were
produced by injecting 2.8 105 sh9 or c4 cells/0.1 ml phosphate-
buffered saline into the lateral tail vein of female 8-week-old C57BL/
6J mice. After 16 days of injection, lungs were isolated and the visible
metastatic nodules on the lung surface were counted.
FRET analysis
The fluorescence images were captured using a dual wavelength ratio
imaging system (Hamamatsu Photonics, Shizuoka, Japan) consisting
of a C9100-13 EM-CCD camera and W-View optics coupled to a
Nikon TE2000 inverted fluorescence microscope equipped with
a Nikon S Fluor (Nikon, Tokyo, Japan) 60 oil immersion objective
(NA 1.3) (Tanimura et al., 2009). The fluorescence of PIP3 biosensors
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was monitored with excitation at 425 nm and dual emission at 480
and 535 nm. AquaCosmos 2.6 software (Hamamatsu Photonics) was
used for the image analyses. B16F1 cells permanently expressing fllip-
pm or fllip-pm-R284C were treated with vehicle or 10 mM NAM
overnight and stimulated by PDGF. The duration time was compared
in cells in which PIP3 level increased by PDGF (n¼ 11 for control
cells and n¼ 3 for NAM-treated cells).
Statistical analysis
Data from at least three independent experiments are represented as
means±SD. Differences were tested by unpaired t-test and analysis of
variance. When the overall analysis of variance indicated a significant
difference, multiple comparisons were conducted using the Student–
Newman–Keuls post hoc test. Survival rates were monitored and
compared using the log-rank test. P-values o0.02 were considered
significant. Invasion and lymph node metastasis were compared using
the w2-test. P-values o0.05 were considered significant.
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